195 related articles for article (PubMed ID: 18451730)
1. Retinal hemorrhages in anastrozole users.
Eisner A; Falardeau J; Toomey MD; Vetto JT
Optom Vis Sci; 2008 May; 85(5):301-8. PubMed ID: 18451730
[TBL] [Abstract][Full Text] [Related]
2. Anastrozole for breast cancer: recent advances and ongoing challenges.
Buzdar AU
Expert Rev Anticancer Ther; 2006 Jun; 6(6):839-48. PubMed ID: 16761927
[TBL] [Abstract][Full Text] [Related]
3. Anastrozole: new indication. Adjuvant treatment of non metastatic breast cancer: useful for some patients.
Prescrire Int; 2005 Apr; 14(76):43-4. PubMed ID: 15875334
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors.
Eisner A; Toomey MD; Falardeau J; Samples JR; Vetto JT
Breast Cancer Res Treat; 2007 Dec; 106(2):161-70. PubMed ID: 17260092
[TBL] [Abstract][Full Text] [Related]
5. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
[TBL] [Abstract][Full Text] [Related]
6. Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.
Needleman SJ; Tobias JS
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1871-81. PubMed ID: 19046107
[TBL] [Abstract][Full Text] [Related]
7. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
Dixon JM; Renshaw L; Young O; Murray J; Macaskill EJ; McHugh M; Folkerd E; Cameron DA; A'Hern RP; Dowsett M
J Clin Oncol; 2008 Apr; 26(10):1671-6. PubMed ID: 18375896
[TBL] [Abstract][Full Text] [Related]
8. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
[TBL] [Abstract][Full Text] [Related]
9. Vitreo-retinal traction and anastrozole use.
Eisner A; Thielman EJ; Falardeau J; Vetto JT
Breast Cancer Res Treat; 2009 Sep; 117(1):9-16. PubMed ID: 18712596
[TBL] [Abstract][Full Text] [Related]
10. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
Lycette JL; Luoh SW; Beer TM; Deloughery TG
Breast Cancer Res Treat; 2006 Oct; 99(3):249-55. PubMed ID: 16752073
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.
Bremec T; Demsar J; Luzar B; Pavlović MD
Dermatol Online J; 2009 Jul; 15(7):14. PubMed ID: 19903442
[TBL] [Abstract][Full Text] [Related]
12. Anastrozole (Arimidex) vs. tamoxifen for treatment of early breast cancer.
Med Lett Drugs Ther; 2003 Mar; 45(1152):22-3. PubMed ID: 12637893
[No Abstract] [Full Text] [Related]
13. Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
Schwartzberg LS; Cobb P; Senecal F; Henry D; Kulig K; Walker MS; Houts AC; Stepanski EJ
Breast; 2009 Apr; 18(2):78-83. PubMed ID: 19342237
[TBL] [Abstract][Full Text] [Related]
14. Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.
Okunade G; Green AR; Ying M; Agrawal A; Paish EC; Aleskandrany M; Winterbottom L; Hassell K; Morgan DA; Ellis IO; Cheung KL
Crit Rev Oncol Hematol; 2009 Oct; 72(1):76-82. PubMed ID: 19515574
[TBL] [Abstract][Full Text] [Related]
15. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Aug; 18(8):811-21. PubMed ID: 19085975
[TBL] [Abstract][Full Text] [Related]
16. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
Stilwill SE; Cooper BC
J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
[TBL] [Abstract][Full Text] [Related]
17. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
Wardley AM
Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768
[TBL] [Abstract][Full Text] [Related]
18. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.
Lejbak L; Vrbancic M; Crossley M
J Clin Exp Neuropsychol; 2010 Oct; 32(8):836-46. PubMed ID: 20336566
[TBL] [Abstract][Full Text] [Related]
20. Small optic cup sizes among women using tamoxifen: assessment with scanning laser ophthalmoscopy.
Eisner A; O'Malley JP; Incognito LJ; Toomey MD; Samples JR
Curr Eye Res; 2006 Apr; 31(4):367-79. PubMed ID: 16603470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
